Edition:
United Kingdom

People: Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

14.17USD
22 Jul 2019
Change (% chg)

-- (--)
Prev Close
$14.17
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
208,210
52-wk High
$16.38
52-wk Low
$2.62

Lupher, Mark 

Dr. Mark Lupher Jr. Ph.D. is Director of the company. Mark Lupher, Ph.D. is a biopharmaceutical executive with over 28 years of experience with biomedical research organizations and over 12 years of experience serving in various executive level roles. He currently serves as the Vice President of translational pharmacology and preclinical development at Sutro Biopharma, a biotechnology company focused on clinical-stage drug discovery, development and manufacturing. Dr. Lupher also currently serves as the President and Founder of VeritasRx Consulting, an executive consulting service he founded in 2013. Previously, Dr. Lupher held a variety of executive roles at biopharmaceutical companies, including serving as Chief Scientific Officer at Promedior, Inc. `. Lupher received a Ph.D. in immunology from Harvard University and a B.S. in microbiology from the University of Washington.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --